The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 19, 2024
Filed:
May. 17, 2021
Applicant:
Jcr Pharmaceuticals Co., Ltd., Hyogo, JP;
Inventors:
Hiroyuki Sonoda, Kobe, JP;
Kenichi Takahashi, Kobe, JP;
Assignee:
JCR Pharmaceuticals Co., Ltd., Hyogo, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 47/68 (2017.01); C07K 16/46 (2006.01); C12N 9/16 (2006.01); C12N 15/62 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2881 (2013.01); A61K 47/6809 (2017.08); A61K 47/6813 (2017.08); A61K 47/6815 (2017.08); C07K 16/2806 (2013.01); C07K 16/46 (2013.01); C12N 9/16 (2013.01); C12N 15/62 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01);
Abstract
Provided is an anti-human transferrin receptor antibody or an analog thereof, wherein in the heavy chain variable region of the antibody, (a) CDR1 comprises the amino acid sequence set forth as SEQ ID NO: 62 or SEQ ID NO: 63, (b) CDR2 comprises the amino acid sequence set forth as SEQ ID NO: 13 or SEQ ID NO: 14, and (c) CDR3 comprises the amino acid sequence set forth as SEQ ID NO: 15 or SEQ ID NO: 16, and an analogue thereof.